NASDAQ: TDAC
Translational Development Acquisition Corp Earnings Dates, Reports, Calls

Translational Development Acquisition earnings were $6.2M for the trailing 12 months ending Mar 31, 2026, with 460% growth year over year. The latest TDAC earnings report on Mar 31, 2026 announced Q1 2026 earnings of $1.3M, down 16.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TDAC reported annual earnings of $6.4M, with -9,059.7% growth.

TDAC past earnings growth

How has TDAC's earnings growth performed historically?

Company
460%
Industry
1.28%
Market
83.56%
TDAC's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
TDAC's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
TDAC's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

TDAC earnings history

Current Revenue
$0.0
Current Earnings
$6.2M
Current Profit Margin
0%

TDAC Return on Equity

Current Company
-95.9%
Current Industry
108.2%
Current Market
13.5%
TDAC's Return on Equity (-95.9%)... subscribe to Premium to read more.
High Return on Equity Performance

TDAC Return on Assets

Current Company
3.4%
Current Industry
-2.6%
TDAC is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TDAC announces earnings.

TDAC Return on Capital Employed

Current Company
3.4%
Current Industry
-1.5%

TDAC vs Shell Company Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TDAC$6.21M$6.21M+460.00%$0.28
TDWDN/AN/AN/AN/A
AACPN/AN/AN/AN/A
TWLVN/AN/AN/AN/A
MACI$5.43M$4.74M-18.52%$0.22

Translational Development Acquisition Earnings Reports & History FAQ

What were Translational Development Acquisition's earnings last quarter?

Translational Development Acquisition (NASDAQ: TDAC) reported Q1 2026 earnings per share (EPS) of $0.06, up 14.29% year over year. Total TDAC earnings for the quarter were $1.33 million. In the same quarter last year, Translational Development Acquisition's earnings per share (EPS) was $0.07.

If you're new to stock investing, here's how to buy Translational Development Acquisition stock.

Is Translational Development Acquisition profitable or losing money?

As of the last Translational Development Acquisition earnings report, Translational Development Acquisition is currently profitable. Translational Development Acquisition's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $6.21 million, a 339.93% increase year over year.

What was TDAC's earnings growth in the past year?

As of Translational Development Acquisition's earnings date in Q2 2026, Translational Development Acquisition's earnings has grown 460% year over year. This is 458.72 percentage points higher than the US Shell Companies industry earnings growth rate of 1.28%. TDAC earnings in the past year totalled $6.21 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.